drugset / Trial / NCT00677352

A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder

NCT00677352

Phase 4 Completed 321 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy and safety of sertraline compared to paroxetine in patients with panic disorder.

Timeline

Start
2008-05
Primary completion
2010-01
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Paroxetine Small molecule 10 mg
Subject Sertraline Small molecule 25 mg
Subject Sertraline Small molecule 50 mg

Indications